Cargando…

Abuse risks and routes of administration of different prescription opioid compounds and formulations

BACKGROUND: Evaluation of tamper resistant formulations (TRFs) and classwide Risk Evaluation and Mitigation Strategies (REMS) for prescription opioid analgesics will require baseline descriptions of abuse patterns of existing opioid analgesics, including the relative risk of abuse of existing prescr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butler, Stephen F, Black, Ryan A, Cassidy, Theresa A, Dailey, Taryn M, Budman, Simon H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213066/ https://www.ncbi.nlm.nih.gov/pubmed/22011626 http://dx.doi.org/10.1186/1477-7517-8-29

Ejemplares similares

How did you know you got the right pill? Prescription opioid identification and measurement error in the abuse deterrent formulation era
por: Green, Traci C, et al.
Publicado: (2015)

Patterns of abuse and routes of administration for immediate‐release hydrocodone combination products
por: Cassidy, Theresa A., et al.
Publicado: (2017)

Typologies of Prescription Opioid Use in a Large Sample of Adults Assessed for Substance Abuse Treatment
por: Green, Traci C., et al.
Publicado: (2011)

Relative Abuse of Crush-Resistant Prescription Opioid Tablets via Alternative Oral Modes of Administration
por: Butler, Stephen F, et al.
Publicado: (2018)

Can abuse deterrent formulations make a difference? Expectation and speculation
por: Budman, Simon H, et al.
Publicado: (2009)

Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV)
por: Vosburg, Suzanne K, et al.
Publicado: (2019)

Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers
por: Butler, Stephen F, et al.
Publicado: (2006)

Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
por: Darwish, Mona, et al.
Publicado: (2017)

The effect of an abuse‐deterrent opioid formulation (OxyContin) on opioid abuse‐related outcomes in the postmarketing setting
por: Coplan, PM, et al.
Publicado: (2016)

Patient perspectives of transitioning from prescription opioids to heroin and the role of route of administration
por: Monico, Laura B., et al.
Publicado: (2018)

Prescription opioid abuse: pharmacists’ perspective and response
por: Cochran, Gerald, et al.
Publicado: (2016)

Economic Burden of Prescription Opioid Misuse and Abuse
por: Strassels, Scott
Publicado: (2009)

Route of administration for illicit prescription opioids: a comparison of rural and urban drug users
por: Young, April M, et al.
Publicado: (2010)

Prescription Drug Monitoring Programs and Other Interventions to Combat Prescription Opioid Abuse
por: Chakravarthy, Bharath, et al.
Publicado: (2012)

Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index—Multimedia Version (ASI-MV(®)) Network
por: Green, Jody L., et al.
Publicado: (2020)

Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs
por: Cleland, Charles M, et al.
Publicado: (2011)

Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy
por: Reisman, Richard M., et al.
Publicado: (2009)

Formulation Strategies of Nanosuspensions for Various Administration Routes
por: Pınar, Sıla Gülbağ, et al.
Publicado: (2023)

Nonmedical Use of Xtampza(®) ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV(®))
por: Green, Jody L, et al.
Publicado: (2021)

Mitigation of IV Abuse Through the Use of Abuse‐Deterrent Opioid Formulations: An Overview of Current Technologies
por: Rauck, Richard L.
Publicado: (2019)

Reflections on the role of opioids in the treatment of chronic pain: a shared solution for prescription opioid abuse and pain
por: Thomas, D., et al.
Publicado: (2015)

Estimating the health care burden of prescription opioid abuse in five European countries
por: Shei, Amie, et al.
Publicado: (2015)

Prescription Opioid Abuse: Gleaning insights from hospital and vital records data
por: Sundaram-Stukel, Reka, et al.
Publicado: (2017)

Opioids Use and Abuse: Prescription Practice, Attitude, and Beliefs among Doctors of Karachi
por: Majid, Zainab, et al.
Publicado: (2019)

Web-Based Prescription Opioid Abuse Prevention for Adolescents: Program Development and Formative Evaluation
por: Moore, Sarah K, et al.
Publicado: (2019)

Racial-Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse
por: Singhal, Astha, et al.
Publicado: (2016)

How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users
por: Butler, Stephen F, et al.
Publicado: (2020)

Trends in dispensing of individual prescription opioid formulations, Canada 2005–2020
por: Jones, Wayne, et al.
Publicado: (2022)

Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse
por: Troiani, Vanessa, et al.
Publicado: (2021)

Administration and Prescription of Opioids in Emergency Departments: A Retrospective Study
por: McNeil, Casey L., et al.
Publicado: (2021)

Modeling Opioid Abuse: A Case Study of the Opioid Crisis in New England
por: Butler, Cole, et al.
Publicado: (2023)

Non-medical Use of Prescription Stimulants Among College Students: Non-oral Routes of Administration, Risk Factors, Motivations, and Pathways
por: Butler, Stephen F., et al.
Publicado: (2021)

Utilization of the Arkansas Prescription Monitoring Program to combat prescription drug abuse
por: Rittenhouse, Rebecca, et al.
Publicado: (2015)

The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse
por: Cicero, Theodore J., et al.
Publicado: (2017)

The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
por: Reinhart, Marcia, et al.
Publicado: (2018)

An overview of abuse-deterrent opioids and recommendations for practical patient care
por: Adler, Jeremy A, et al.
Publicado: (2018)

Feasibility of Tablet Computer Screening for Opioid Abuse in the Emergency Department
por: Weiner, Scott G., et al.
Publicado: (2015)

A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
por: Jewell, Jennifer, et al.
Publicado: (2023)

Prescription Sedative Misuse and Abuse
por: Weaver, Michael F.
Publicado: (2015)

An overview of available drugs for management of opioid abuse during pregnancy
por: Laslo, Jillian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ukita7f37lj3k27tdg9g6lrmv6